Outset Medical EVP receives 96,000-share RSU grant

Elliott Derick A. reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 04/08/2026 - 05:21 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Elliott Derick A. reported acquisition or exercise transactions in this Form 4 filing.

Outset Medical, Inc. executive Elliott Derick A., EVP, Commercial, received a grant of 96,000 shares of common stock in the form of restricted stock units at $0.00 per share as equity compensation. The RSUs vest 33.33% on April 6, 2027, with the remaining 66.66% vesting in equal quarterly installments over the next two years, subject to continuous service. Following this award, he holds 96,000 shares directly.

Insider Trade Summary

Grant/Award: 96,000 shares

Grant/Award 1 txn

Insider Elliott Derick A.

Role EVP, Commercial

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	96,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 96,000 shares (Direct)

Footnotes (1)

1. F1. Represents restricted stock units ("RSU") granted to the reporting person on April 6, 2026. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on April 6, 2027, and the remaining 66.66% shall vest in equal installments over the course of the following two years on a quarterly basis on February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date.

Key Figures

RSUs granted: 96,000 shares Grant price: $0.00 per share Initial vesting tranche: 33.33% of RSUs +2 more

5 metrics

RSUs granted 96,000 shares Restricted stock units of common stock granted April 6, 2026

Grant price $0.00 per share Reported transaction price for RSU award

Initial vesting tranche 33.33% of RSUs Vests on April 6, 2027, subject to continuous service

Remaining vesting portion 66.66% of RSUs Vests quarterly over following two years on Feb 15, May 15, Aug 15, Nov 15

Shares held after grant 96,000 shares Total common stock reported as directly owned following transaction

Key Terms

restricted stock units, contingent right, continuous service, vesting

4 terms

restricted stock units financial

"Represents restricted stock units ("RSU") granted to the reporting person on April 6, 2026."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"Each RSU represents a contingent right to receive one share of common stock."

continuous service financial

"subject to the reporting person's continuous service through the applicable vesting date."

vesting financial

"These RSUs shall vest 33.33% on April 6, 2027, and the remaining 66.66% shall vest in equal installments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Outset Medical (OM) report for Elliott Derick A.?

Outset Medical reported that EVP, Commercial, Elliott Derick A. received a grant of 96,000 restricted stock units of common stock. The award is equity compensation, not an open-market purchase or sale, and was reported as an acquisition on a Form 4 filing.

How many Outset Medical (OM) shares were granted in this Form 4 filing?

The filing shows a grant of 96,000 restricted stock units, each representing one share of Outset Medical common stock. All 96,000 shares are reported as directly owned following the transaction, reflecting a new equity award to the executive vice president, commercial.

At what price were the Outset Medical (OM) RSUs granted in this Form 4?

The 96,000 restricted stock units were granted at a reported price of $0.00 per share, consistent with an equity compensation award. This indicates the executive did not pay cash for the shares; they are subject to future vesting conditions.

What is the vesting schedule for the 96,000 Outset Medical (OM) RSUs?

The RSUs vest 33.33% on April 6, 2027. The remaining 66.66% vest in equal installments over the following two years on February 15, May 15, August 15, and November 15, provided the executive maintains continuous service through each vesting date.

Are the granted RSUs in Outset Medical (OM) immediately owned as common stock?

Each restricted stock unit represents a contingent right to receive one share of common stock. The units convert into shares only as they vest under the schedule, and continued service is required for the executive to earn each future installment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Elliott Derick A.

(Last) (First) (Middle)

3052 ORCHARD DRIVE

(Street)

SAN JOSE CALIFORNIA 95134

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Outset Medical, Inc. [ OM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Commercial

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/06/2026		A		96,000(1)	A	$0.0	96,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSU") granted to the reporting person on April 6, 2026. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on April 6, 2027, and the remaining 66.66% shall vest in equal installments over the course of the following two years on a quarterly basis on February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date.

	By: John L Brottem For: Derick Elliott	04/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)